Every industry and region has an anchor event where the future of the sector is not only discussed but visibly assembled. For Africa’s pharmaceutical economy, that gathering is Pharmaconex, the beating heart of a market on the cusp of $60 billion in value.
Held every September in Cairo, it is no longer accurate to describe Pharmaconex as a trade fair. Over the past decade, it has become a continental lodestar where Africa’s pharmaceutical self-sufficiency is debated, tested, and materially advanced.
modest beginnings. bright future
Pharmaconex began as a modest gathering: eleven exhibitors and a few hundred attendees. It was a niche platform for a still-fledgling sector heavily dependent on imports and fragmented across national borders. Today it has grown to more than 350 exhibitors and 13,500 visitors, with delegations from over 40 countries.
The show’s growth mirrors Egypt’s own pharmaceutical trajectory. Since 2015, the country has expanded from 130 factories to more than 170, becoming the 29th largest producer globally. Pharmaconex is both a mirror and a megaphone of this evolution, reflecting local industry capacity while amplifying its ambition to continental and global audiences.
“Pharmaconex is a catalyst for regional transformation,” says show director Mostapha Khalil. “A platform that str”ngthens Egypt’s role as the biopharmaceutical gateway “o the African continent, and accelera”es localisation, industrial connectivity, and regulatory progress.”
pharmaconex matters
Africa’s health and pharmaceutical sectors are defined by contradictions. The population is”vast and growing. Chronic disease is rising, and demand for medicines keeps outpacing supply. Yet the continent depends heavily on imports. Supply chains are fragile, and local production cannot keep up. This paradox of enormous need, enormous opportunity, along with the “triple burden” of disease, infectious and non-communicable, now lifestyle as well, continues to stretch systems.”Solving these”contradictions requires political and industry will. It also requires collaborative ecosystems and manufacturing capacity. Local production is now essential.
Pharmaconex addresses this head-on. It is where governments, regulators, manufacturers, investors, and academics gather to exchange ideas and lay down pathways to fruition. Self-sufficiency and localisation, repeated themes in continental policy, are translated into procurement contracts, technology transfer agreements, and facility designs.
marketplace and classroom
Pharmaconex has always been dual in nature: both marketplace and classroom. On the floor, exhibitors meet decision-makers: buyers and distributors, regulators and investors. In conference halls, delegates engage with technical and strategic issues: cleanroom standards, Pharma 4.0 automation, sustainable facility design, and regulatory compliance.
Mostapha says this dual identity is deliberate. “We want to build competence as much as connections. A strong pharmaceutical sector cannot rely only on imported “xpertise. Skills and knowledge must be localised alongside manufacturing.”
The 2025 edition of Pharmaconex is structured around seven tracks that mirror the region’s priorities: pharmace”tical market growth and government initiatives, regional insights and investment opportunities, AI, digital transformation and automation, nutraceuticals and functional foods, supply chain resilience, sustainable pharmaceutical facilities, and containment solutions and compliance. Within these, three themes dominate the discussion: artificial intelligence, cleanroom innovation, sustainability. Each is a transformational force shaping the future of Africa’s pharmaceutical industry.
global reach, local impact
Localisation and regulatory harmonisation are prerequisites for reducing dependence on imports. At Pharmaconex, the region’s dependence on imports is openly confronted. While the event serves as Africa’s window to global expertise, it is also a vital channel for localisation: it supports the region’s drive to reduce dependence on imported APIs and to widen its manufacturing base, and positions African producers for export markets.
Participation from across the continent enables Egyptian and regional manufacturers to connect with global markets, while also inviting international suppliers to participate in Africa’s localisation drive.
The event brings government and regulators together with industry, building partnerships to strengthen domestic capacity. Commitments get announced and partnerships launched. Regional strategies fall into alignment. Pharmaconex also attracts delegations from India and China, as well as from major EU states. Each international partnership has the potential for investment or technology transfer, or for a joint venture that expands Africa’s manufacturing base.
This dual orientation, looking outward while strengthening what it builds at home, is what makes Pharmaconex distinct. It stands at the crossroads where global expertise meets African demand, where Africa shapes the global pharmaceutical order rather than only receiving from it.
listening, learning, improving
Pharmaconex is also iterative. After each edition, organisers conduct a comprehensive survey of exhibitors and visitors, which feeds directly into programme design. This culture of listening ensures that the event evolves with the sector itself, so that it feels like a community platform rather than a trade fair. This responsiveness has enabled Pharmaconex to grow in size and relevance. Conferences that once drew 100 delegates now attract over 1,500. Exhibitor halls that held a few dozen companies have given way to sector-specific zones. The event has scaled, but with purpose.
continental megaphone
Africa’s biopharma transformation rests on five urgent levers: localisation of manufacturing, regulatory harmonisation, digital transformation, investment in human capital, and harnessing biodiversity for innovation. Pharmaconex touches all five. It stages localisation debates, hosts regulators, integrates digital transformation in its technical agenda, supports training and education, and provides a platform for innovators. Its thematic structure reflects the priorities that shape continental strategies such as the African Medicines Agency (AMA) and the Partnership for African Vaccine Manufacturing (PAVM).
Pharmaconex is curated to ensure its agenda reflects Africa’s pharmaceutical moment and to amplify it to the world.
convergence
As the exhibition floor reverberates with countless conversations that will shape the next decade, one truth is clear: Pharmaconex is where ideas converge with partnerships and ambitions.
In true Linchpin style, Pharmaconex convenes the actors who can turn strategy into practice, the people who put Africa’s pharmaceutical trajectory into actual construction rather than leaving it imagined.
